158 related articles for article (PubMed ID: 36790465)
1. Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension.
Widmann L; Keranov S; Jafari L; Liebetrau C; Keller T; Troidl C; Kriechbaum S; Voss S; Arsalan M; Richter MJ; Tello K; Gall H; Ghofrani HA; Guth S; Seeger W; Hamm CW; Dörr O; Nef H
Clin Res Cardiol; 2023 Oct; 112(10):1382-1393. PubMed ID: 36790465
[TBL] [Abstract][Full Text] [Related]
2. Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction.
Schmeißer A; Rauwolf T; Groscheck T; Fischbach K; Kropf S; Luani B; Tanev I; Hansen M; Meißler S; Schäfer K; Steendijk P; Braun-Dullaeus RC
ESC Heart Fail; 2021 Aug; 8(4):2968-2981. PubMed ID: 33934536
[TBL] [Abstract][Full Text] [Related]
3. RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes.
Guazzi M; Dixon D; Labate V; Beussink-Nelson L; Bandera F; Cuttica MJ; Shah SJ
JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt B):1211-1221. PubMed ID: 28412423
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension.
Keranov S; Dörr O; Jafari L; Liebetrau C; Keller T; Troidl C; Riehm J; Rutsatz W; Bauer P; Kriechbaum S; Voss S; Richter MJ; Tello K; Gall H; Ghofrani HA; Guth S; Seeger W; Hamm CW; Nef H
Biomark Med; 2021 Aug; 15(12):1021-1034. PubMed ID: 34289706
[No Abstract] [Full Text] [Related]
5. Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension.
Tello K; Wan J; Dalmer A; Vanderpool R; Ghofrani HA; Naeije R; Roller F; Mohajerani E; Seeger W; Herberg U; Sommer N; Gall H; Richter MJ
Circ Cardiovasc Imaging; 2019 Sep; 12(9):e009047. PubMed ID: 31500448
[TBL] [Abstract][Full Text] [Related]
6. SPARCL1 as a biomarker of maladaptive right ventricular remodelling in pulmonary hypertension.
Keranov S; Dörr O; Jafari L; Liebetrau C; Keller T; Troidl C; Kriechbaum S; Voss S; Richter M; Tello K; Gall H; Ghofrani HA; Mayer E; Seeger W; Hamm CW; Nef H
Biomarkers; 2020 May; 25(3):290-295. PubMed ID: 32248722
[No Abstract] [Full Text] [Related]
7. CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension.
Keranov S; Dörr O; Jafari L; Troidl C; Liebetrau C; Kriechbaum S; Keller T; Voss S; Bauer T; Lorenz J; Richter MJ; Tello K; Gall H; Ghofrani HA; Mayer E; Wiedenroth CB; Guth S; Lörchner H; Pöling J; Chelladurai P; Pullamsetti SS; Braun T; Seeger W; Hamm CW; Nef H
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33184116
[TBL] [Abstract][Full Text] [Related]
8. Pressure-volume loop validation of TAPSE/PASP for right ventricular arterial coupling in heart failure with pulmonary hypertension.
Schmeisser A; Rauwolf T; Groscheck T; Kropf S; Luani B; Tanev I; Hansen M; Meißler S; Steendijk P; Braun-Dullaeus RC
Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(2):168-176. PubMed ID: 33167032
[TBL] [Abstract][Full Text] [Related]
9. Is Right Ventricular Remodeling in Pulmonary Hypertension Dependent on Etiology? An Echocardiographic Study.
Giusca S; Popa E; Amzulescu MS; Ghiorghiu I; Coman IM; Popescu BA; Delcroix M; Voigt JU; Ginghina C; Jurcut R
Echocardiography; 2016 Apr; 33(4):546-54. PubMed ID: 26542101
[TBL] [Abstract][Full Text] [Related]
10. Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure.
Legris V; Thibault B; Dupuis J; White M; Asgar AW; Fortier A; Pitre C; Bouabdallaoui N; Henri C; O'Meara E; Ducharme A;
ESC Heart Fail; 2022 Feb; 9(1):450-464. PubMed ID: 34953062
[TBL] [Abstract][Full Text] [Related]
11. Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension.
Kim J; Krichevsky S; Xie L; Palumbo MC; Rodriguez-Diego S; Yum B; Brouwer L; Silver RT; Schafer AI; Ritchie EK; Yabut MM; Sosner C; Horn EM; Devereux RB; Scandura JM; Weinsaft JW
J Am Soc Echocardiogr; 2019 Dec; 32(12):1574-1585. PubMed ID: 31587969
[TBL] [Abstract][Full Text] [Related]
12. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
[TBL] [Abstract][Full Text] [Related]
13. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.
Rich JD; Thenappan T; Freed B; Patel AR; Thisted RA; Childers R; Archer SL
Int J Cardiol; 2013 Aug; 167(3):669-76. PubMed ID: 22459397
[TBL] [Abstract][Full Text] [Related]
14. The value of speckle-tracking echocardiography in identifying right heart dysfunction in patients with chronic thromboembolic pulmonary hypertension.
Li AL; Zhai ZG; Zhai YN; Xie WM; Wan J; Tao XC
Int J Cardiovasc Imaging; 2018 Dec; 34(12):1895-1904. PubMed ID: 30062538
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
[TBL] [Abstract][Full Text] [Related]
16. GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertension.
Keranov S; Widmann L; Jafari L; Liebetrau C; Keller T; Troidl C; Kriechbaum S; Voss S; Bauer P; Richter MJ; Tello K; Gall H; Ghofrani HA; Wiedenroth CB; Guth S; Seeger W; Hamm CW; Nef H; Dörr O
Biomark Med; 2022 Dec; 16(17):1193-1207. PubMed ID: 36790217
[No Abstract] [Full Text] [Related]
17. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA
Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307
[TBL] [Abstract][Full Text] [Related]
18. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.
Tedford RJ; Mudd JO; Girgis RE; Mathai SC; Zaiman AL; Housten-Harris T; Boyce D; Kelemen BW; Bacher AC; Shah AA; Hummers LK; Wigley FM; Russell SD; Saggar R; Saggar R; Maughan WL; Hassoun PM; Kass DA
Circ Heart Fail; 2013 Sep; 6(5):953-63. PubMed ID: 23797369
[TBL] [Abstract][Full Text] [Related]
19. Combined evaluation of right ventricular function using echocardiography in non-ischaemic dilated cardiomyopathy.
Ishiwata J; Daimon M; Nakanishi K; Sugimoto T; Kawata T; Shinozaki T; Nakao T; Hirokawa M; Sawada N; Yoshida Y; Amiya E; Hatano M; Morita H; Yatomi Y; Komuro I
ESC Heart Fail; 2021 Oct; 8(5):3947-3956. PubMed ID: 34346188
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19.
Li Y; Li H; Zhu S; Xie Y; Wang B; He L; Zhang D; Zhang Y; Yuan H; Wu C; Sun W; Zhang Y; Li M; Cui L; Cai Y; Wang J; Yang Y; Lv Q; Zhang L; Xie M
JACC Cardiovasc Imaging; 2020 Nov; 13(11):2287-2299. PubMed ID: 32654963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
